# Biotech investors in Australia (2026 list)

> 105 biotech investors in Australia, 78% active in the last 12 months. Led by Accel, MassChallenge, SOSV. Ranked by what they funded.

Source: https://millionrounds.com/lists/biotech-investors-in-australia (Millionrounds; every figure on the page links to its filing or article)

[Investor Lists](https://millionrounds.com/lists)

# Biotech investors in Australia

Updated 7 November 2026

Firms observed backing a biotech company in Australia in the last two years, wherever the firm is based.

[See all 105 *→*](https://millionrounds.com/login?join=1&next=%2Fapp%2Finvestor-lists%2Fbiotech-investors-in-australia)The top 25

**105** investors on the list *+1* this week

**1,010** cheques in 12 months *-12%* against the market

**$12M** median round they joined *+45%* against the market median

**78%** wrote a cheque in 12 months

**54%** have led a round

## The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (25)

- 1 [Accel](https://millionrounds.com/fund/accel) *Deploying now* VC firm · United States **1,341** **$32M** median round **Nov 2026** last seen
- 2 [MassChallenge](https://millionrounds.com/fund/masschallenge) *Deploying now* Accelerator · United States **984** **$1.8M** median round **Sept 2026** last seen
- 3 [SOSV](https://millionrounds.com/fund/sosv) *Deploying now* VC firm · United States **951** **$2.5M** median round **Nov 2026** last seen
- 4 [Innovate UK](https://millionrounds.com/fund/innovate-uk) *Deploying now* VC firm · United Kingdom **704** **$1.2M** median round **Oct 2026** last seen
- 5 [Fidelity](https://millionrounds.com/fund/fidelity) *Deploying now* VC firm · United States **360** **$119M** median round **Nov 2026** last seen
- 6 [In-Q-Tel](https://millionrounds.com/fund/iqt) *Deploying now* Accelerator · United States **273** **$20M** median round **Nov 2026** last seen
- 7 [Morningside Group](https://millionrounds.com/fund/morningside) *Deploying now* VC firm · United States **225** **$24M** median round **Jul 2026** last seen
- 8 [Artesian VC](https://millionrounds.com/fund/artesian) *Deploying now* Asset manager · Australia **201** **$2M** median round **Oct 2026** last seen
- 9 [Horizons Ventures](https://millionrounds.com/fund/horizons-ventures) *Deploying now* VC firm · Hong Kong SAR China **186** **$19M** median round **Sept 2026** last seen
- 10 [IP Group](https://millionrounds.com/fund/ip-group) *Deploying now* VC firm · United Kingdom **174** **$9.1M** median round **Oct 2026** last seen
- 11 [MedTech Innovator](https://millionrounds.com/fund/medtech-innovator) *Deploying now* Accelerator · United States **160** **$2.8M** median round **Sept 2026** last seen
- 12 [Eli Lilly](https://millionrounds.com/fund/eli-lilly) *Deploying now* Corporate VC · United States **137** **$56M** median round **Nov 2026** last seen
- 13 [T. Rowe Price](https://millionrounds.com/fund/t-rowe-price) *Deploying now* Private equity · United States **136** **$400M** median round **Nov 2026** last seen
- 14 [Development Bank of Wales](https://millionrounds.com/fund/development-bank-of-wales) *Deploying now* Government · United Kingdom **123** **$1.3M** median round **Oct 2026** last seen
- 15 [Investible](https://millionrounds.com/fund/investible) *Deploying now* VC firm · Australia **123** **$2.4M** median round **Aug 2026** last seen
- 16 [iSeed](https://millionrounds.com/fund/iseed) *Deploying now* VC firm · India **118** **$2.6M** median round **Sept 2026** last seen
- 17 [Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) *Deploying now* VC firm · United States **108** **$73M** median round **Oct 2026** last seen
- 18 [Startmate](https://millionrounds.com/fund/startmate) *Deploying now* Accelerator · Australia **107** **$1.6M** median round **Sept 2026** last seen
- 19 [Sanofi](https://millionrounds.com/fund/sanofi) *Deploying now* Investment firm · France **97** **$60M** median round **Aug 2026** last seen
- 20 [Big Idea Ventures](https://millionrounds.com/fund/big-idea-ventures) *Deploying now* VC firm · United States **84** **$1.3M** median round **Sept 2026** last seen
- 21 [Main Sequence Ventures](https://millionrounds.com/fund/main-sequence) *Deploying now* VC firm · Australia **84** **$13M** median round **Sept 2026** last seen
- 22 [Praetura Ventures](https://millionrounds.com/fund/praetura-ventures) *Deploying now* VC firm · United Kingdom **79** **$3.5M** median round **Sept 2026** last seen
- 23 [Abingworth](https://millionrounds.com/fund/abingworth) *Deploying now* VC firm · United Kingdom **75** **$84M** median round **Jul 2026** last seen
- 24 [AgFunder](https://millionrounds.com/fund/agfunder) *Deploying now* VC firm · United States **74** **$5.5M** median round **Oct 2026** last seen
- 25 [Alpha Wave Global](https://millionrounds.com/fund/alpha-wave-global) *Deploying now* Private equity · United States **70** **$48M** median round **Oct 2026** last seen

**80 more on this list**

All 105 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

[See the whole list *→*](https://millionrounds.com/login?join=1&next=%2Fapp%2Finvestor-lists%2Fbiotech-investors-in-australia)

## The Newest Cheques

Rounds this list's investors joined most recently

- **6** Nov **[Ocient](https://millionrounds.com/company/ocient)** Series C · $100M *With* [In-Q-Tel](https://millionrounds.com/fund/iqt)
- **6** Nov **[Thinking Machines Lab](https://millionrounds.com/company/thinking-machines-lab)** Other · $5B *Led by* [Accel](https://millionrounds.com/fund/accel)
- **6** Nov **[Harbinger](https://millionrounds.com/company/harbinger)** Series D+ · $240M *With* [Fidelity](https://millionrounds.com/fund/fidelity)
- **5** Nov **[T-Therapeutics](https://millionrounds.com/company/t-therapeutics)** Series B · $133M *With* [Eli Lilly](https://millionrounds.com/fund/eli-lilly)
- **5** Nov **[RadianX](https://millionrounds.com/company/radianx)** Seed · $9M *Led by* [SOSV](https://millionrounds.com/fund/sosv)
- **5** Nov **[Zipline](https://millionrounds.com/company/zipline)** Growth · $1.5B *With* [Fidelity](https://millionrounds.com/fund/fidelity)

## Stages This Year

841 rounds

- Seed **17%**
- Venture **16%**
- Series A **12%**
- Other **11%**
- Grant **10%**
- Other **35%**

## What They Backed

Sectors, last 12 months

- AI **243**
- Biotech **173**
- Healthcare **95**
- Agtech **46**
- Energy **40**
- Big Data & Analytics **39**

## Cheques by Quarter

Led Joined

294 Q1 25

267 Q2 25

324 Q3 25

336 Q4 25

311 Q1 26

239 Q2 26

264 Q3 26

75 Q4 26

The last bar is the quarter still running.

## Lists Like This

- [AI investors in United States 3,683](https://millionrounds.com/lists/ai-investors-in-united-states)
- [Fintech investors in United States 1,166](https://millionrounds.com/lists/fintech-investors-in-united-states)
- [AI investors in United Kingdom 1,039](https://millionrounds.com/lists/ai-investors-in-united-kingdom)
- [Big Data & Analytics investors in United States 1,039](https://millionrounds.com/lists/big-data-investors-in-united-states)
- [Biotech investors in United States 914](https://millionrounds.com/lists/biotech-investors-in-united-states)
- [Energy investors in United States 798](https://millionrounds.com/lists/energy-investors-in-united-states)
- [Robotics investors in United States 797](https://millionrounds.com/lists/robotics-investors-in-united-states)
- [Construction investors in United States 742](https://millionrounds.com/lists/construction-investors-in-united-states)
- [Cybersecurity investors in United States 702](https://millionrounds.com/lists/cybersecurity-investors-in-united-states)

[All investor lists *→*](https://millionrounds.com/lists)

## Reading for founders in health and biotech

- The Innovator's Prescription: A Disruptive Solution for Health Care Clayton M. Christensen · 2008 4.21 from 1,158 ratings on Goodreads Health and biotech Innovation Moats and competition About the book A groundbreaking prescription for health care reform--from a legendary leader in innovation... Our health care system is in critical condition. Each year, fewer Americans can afford it, fewer businesses can provide it, and fewer government programs can promise it for future… On AmazonListen on Audible
- Where Does It Hurt?: An Entrepreneur's Guide to Fixing Health Care Jonathan Bush · 2014 3.78 from 598 ratings on Goodreads Health and biotech Company building Innovation About the book A bold new remedy for the sprawling and wasteful health care industry Where else but the doctor’s office do you have to fill out a form on a clipboard? Have you noticed that hospital bills are almost unintelligible, except for the absurdly high dollar amount? Why is it that… On AmazonListen on Audible
- Ashes to Ashes: America's Hundred-Year Cigarette War, the Public Health, and the Unabashed Triumph of Philip Morris Richard Kluger · 1997 3.94 from 306 ratings on Goodreads Health and biotech Company building About the book Ashes to Ashes is a monumental history of the American tobacco industry’s ironic success in developing the cigarette, modern society’s most widespread instrument of self-destruction, into the nation’s most profitable consumer product. Starting with its energized, work-obsessed… On AmazonListen on Audible
- The Kelloggs: The Battling Brothers of Battle Creek Howard Markel · 2017 3.87 from 969 ratings on Goodreads Health and biotech Company building About the book "What's more American than Corn Flakes?" --Bing Crosby From the much admired medical historian ("Markel shows just how compelling the medical history can be"--Andrea Barrett) and author of An Anatomy of Addiction ("Absorbing, vivid"--Sherwin Nuland, The New York Times Book… On AmazonListen on Audible

More books for founders and investors on the [Reading List](https://millionrounds.com/reading-list?role=founder&industry=health).

As an Amazon Associate we earn from qualifying purchases.

## Quick answers about biotech investors in Australia

### Who are the most active biotech investors in Australia?

By cheques observed, the most active are Accel, MassChallenge, SOSV, Innovate UK and Fidelity.

### How many biotech investors in Australia are there?

105 are on record. 78% made an investment in the last 12 months and 54% have led a round.

### Which stages do biotech investors in Australia back?

Of the rounds with a named stage in the last 12 months, mostly Seed (25%) and Series A (17%).

### How big are the rounds biotech investors in Australia join?

The typical (median) round among the leading investors here is $9.1M.

### Which sectors do biotech investors in Australia back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

### Which biotech investors in Australia lead the most rounds?

Accel (103 led), Fidelity (15 led) and T. Rowe Price (11 led).

### Where are biotech investors in Australia based?

Among the most active, most are based in the United States (13), the United Kingdom (5) and Australia (4).

### What have biotech investors in Australia invested in recently?

Recent rounds include Ocient (Series C, Nov 2026, with In-Q-Tel), Thinking Machines Lab (Other, Nov 2026, with Accel) and Harbinger (Series D+, Nov 2026, with Fidelity).

Built from the rounds we watched, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections)